Delvosteron 100 mg/ml Suspensie voor injectie
Delvosteron 100 mg/ml Suspensie voor injectie
Not authorised
- Proligestone
Product identification
Medicine name:
Delvosteron 100 mg/ml Suspensie voor injectie
Delvosteron 100 mg/ml Suspension injectable
Delvosteron 100 mg/ml Injektionssuspension
Active substance:
- Proligestone
Target species:
-
Dog
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Proligestone100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG03DA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Belgium
Package description:
- Delvosteron 20 ml Vial Suspension for injection
- Delvosteron 10 ml Vial Suspension for injection
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V117381
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
